Poland· PL-100046884

Nervinex-fix

A medicinal product containing produkt ziołowy, registered in Poland by Krakowskie Zakłady Zielarskie "Herbapol" w Krakowie S.A..

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNervinex-fixATC—REGISTER NO.PL-100046884PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Produkt ziołowy
Manufacturer
Krakowskie Zakłady Zielarskie "Herbapol" w Krakowie S.A.
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990021819

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8a1ce772-0a1a-4a3b-9fca-3c32f4a4ea8a
GET /v1/drugs/8a1ce772-0a1a-4a3b-9fca-3c32f4a4ea8a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Zioła do zaparzania w saszetkach",
  "source": "urpl",
  "strength": "-",
  "packaging": "05909990021819 ¦ OTC ¦ 7018\n25 sasz. 2 g",
  "substance": "Melissae folium 20 g + Leonuri cardiacae herba 20 g + Lavandulae flos 10 g + Archangelicae radix 10 g + Rosae pseudo-fructus 20 g + Lupuli strobilus 20 g",
  "common_name": "Produkt ziołowy",
  "pl_product_id": "100046884",
  "pozwolenie_nr": "00218",
  "auth_procedure": "NAR",
  "authorisation_validity": "2026-04-03"
}

See everything about produkt ziołowy.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.